Skip to main content

Advertisement

Log in

Philadelphia chromosome-positive secondary acute myeloid leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 We report the case of a 47-year-old patient who developed acute myelogenous leukemia (AML) 18 months after receiving high-dose chemotherapy with peripheral blood progenitor cell support (PBPCT) for relapsed low-grade follicular non-Hodgkin's lymphoma (NHL). Cytogenetic analysis of the leukemic cells showed the translocation (9;22)(q34;q11). In three mitoses, an addiditional Philadelphia chromosome (Ph1) was present. In the literature, Philadelphia chromosome-positive secondary AML has been described only once before in a patient with multiple myeloma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 7 August 1996 / Accepted: 23 September 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stockschläder, M., Fiedler, W., Zander, A. et al. Philadelphia chromosome-positive secondary acute myeloid leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma. Ann Hematol 73, 291–293 (1996). https://doi.org/10.1007/s002770050243

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050243

Keywords

Navigation